Science Explorer Back to mapMap
Discussion
Company · Mölndal · Sweden

Vicore Pharma (Sweden)

Research works
19
▲ 1375% vs 2018-21
Citations
201
10.4 per fractional work
Top-10% rate
6.0%
all institutions 10.0%
Open access
29%
world 40%
International
29%
world 18%

Not ranked overall: Vicore Pharma (Sweden) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Vicore Pharma (Sweden) work in?

In all years, 65% of research at Vicore Pharma (Sweden) is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (64%), Agricultural and Biological Sciences (13%), Economics, Econometrics and Finance (11%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 13 fractional works · 65.1% of its workMedicine: 12 fractional works · 64.3% of its workPulmonary and Respiratory Medicine: 8 fractional works · 38.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 4.1% of its workRheumatology: 1 fractional works · 2.9% of its workSurgery: 1 fractional works · 2.8% of its workInfectious Diseases: 1 fractional works · 2.6% of its workPathology and Forensic Medicine: 0 fractional works · 2.2% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.9% of its workNephrology: 0 fractional works · 1.7% of its workReproductive Medicine: 0 fractional works · 1.7% of its workPhysiology: 0 fractional works · 1.5% of its workNeurology: 0 fractional works · 1.3% of its workBiochemistry: 0 fractional works · 0.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workOncology: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.6% of its workMedical Laboratory Technology: 0 fractional works · 0.6% of its workNursing: 0 fractional works · 0.2% of its workResearch and Theory: 0 fractional works · 0.2% of its workLife Sciences: 3 fractional works · 18.0% of its workAgricultural and Biological Sciences: 3 fractional works · 13.5% of its workFood Science: 2 fractional works · 12.9% of its workAnimal Science and Zoology: 0 fractional works · 0.6% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 3.2% of its workMolecular Biology: 1 fractional works · 2.7% of its workBiochemistry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 0.9% of its workImmunology: 0 fractional works · 0.9% of its workNeuroscience: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 12.7% of its workEconomics, Econometrics and Finance: 2 fractional works · 11.2% of its workEconomics and Econometrics: 2 fractional works · 11.2% of its workSocial Sciences: 0 fractional works · 0.9% of its workHealth: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.6% of its workApplied Psychology: 0 fractional works · 0.6% of its workPhysical Sciences: 1 fractional works · 4.3% of its workMaterials Science: 0 fractional works · 2.6% of its workMaterials Chemistry: 0 fractional works · 2.6% of its workMathematics: 0 fractional works · 1.7% of its workStatistics and Probability: 0 fractional works · 1.7% of its workALL ITS WORKVicore Pharma(Sweden)19fractional works, all years
Life Sciences18%Physical Sciences4%Health Sciences65%Social Sciences13%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine1264.3%
    2. Health Professions00.6%
    3. Nursing00.2%
    1. Agricultural and Biological Sciences313.5%
    2. Biochemistry, Genetics and Molecular Biology13.2%
    3. Immunology and Microbiology00.9%
    4. Neuroscience00.4%
    1. Economics, Econometrics and Finance211.2%
    2. Social Sciences00.9%
    3. Psychology00.6%
    1. Materials Science02.6%
    2. Mathematics01.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.16× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.77× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.22× its world share, 0 worksImmunology and Micro…Mathematics: 1.96× its world share, 0 worksMathematicsHealth Professions: 0.29× its world share, 0 worksHealth ProfessionsMedicine: 3.82× its world share, 11 worksMedicineNursing: 0.59× its world share, 0 worksNursingEconomics, Econometrics and Finance: 7.06× its world share, 2 worksEconomics, Econometr…Psychology: 0.25× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 7.1×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Economics, Econometrics and Finance7.06×2 works
  2. Medicine3.82×11 works
  3. Mathematics1.96×0 works
  4. Immunology and Microbiology1.22×0 works
  5. Biochemistry, Genetics and Molecular Biology0.77×1 works
  6. Nursing0.59×0 works
  7. Health Professions0.29×0 works
  8. Psychology0.25×0 works
  9. Agricultural and Biological Sciences0.16×0 works
  10. Social Sciences0.09×0 works

Who are the top researchers at Vicore Pharma (Sweden)?

Ranked on the quality score, Rohit Batta lead among researchers whose main affiliation is Vicore Pharma (Sweden).

  1. 1 Rohit Batta Sweden · #3,184,056 worldwide 197 citations · 22 works
All ranked researchers at Vicore Pharma (Sweden)

What are the most cited papers from Vicore Pharma (Sweden)?

The most cited paper from Vicore Pharma (Sweden) is "Sintering of fat crystal networks in oil during post‐crystallization processes" (Dorota Johansson, Björn Bergenståhl, 1995), with 122 citations. Next come "Wetting of fat crystals by triglyceride oil and water. 1. The effect of additives" (72) and "Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial" (48).

Most cited papers
#PaperReleasedCitations
1 Sintering of fat crystal networks in oil during post‐crystallization processes Dorota Johansson, Björn Bergenståhl · Journal of the American Oil Chemists Society Aug 1995 122
2 Wetting of fat crystals by triglyceride oil and water. 1. The effect of additives Dorota Johansson, Björn Bergenståhl, Eva Lundgren · Journal of the American Oil Chemists Society Aug 1995 72
3 Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial Göran Tornling, Rohit Batta, Joanna C. Porter et al. · EClinicalMedicine Open access 25 Oct 2021 48
4 Water‐in‐triglyceride oil emulsions. Effect of fat crystals on stability Dorota Johansson, Björn Bergenståhl, Eva Lundgren · Journal of the American Oil Chemists Society Aug 1995 41
5 Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome Ilse C. Schrieks, Anna Nozza, Barbara Elisabeth Stähli et al. · Diabetes Care Open access 14 Jun 2018 40
All 26 most cited papers, with filters and sorting

Which research topics does Vicore Pharma (Sweden) publish most on?

By volume in 2022-now: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension Research and Treatments, Health Systems, Economic Evaluations, Quality of Life and Respiratory and Cough-Related Research.

  1. 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 3 works
  2. 2 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 2 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  4. 4 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  6. 6 Folate and B Vitamins Research Rheumatology 0 works
  7. 7 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  8. 8 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  9. 9 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
  10. 10 Renin-Angiotensin System Studies Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.6%not open71.4%

World: 40% of research is openly available.

with international co-authors29.1%domestic only70.9%

World: 18% is written across borders.

How has Vicore Pharma (Sweden)'s research output changed?

Output in 2022-2025 was 1375% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vicore Pharma (Sweden) as a percentage of every work published that year, 0.000048% in 2024.

still counting0.00020%0.00040%Vicore Pharma (Sweden)0.000063% in 202519801990200020102020

Fractional works of Vicore Pharma (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mölndal

All research institutions in Mölndal

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vicore Pharma (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.